Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma - Concepedia

Concepedia

Publication | Closed Access

Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma

14

Citations

12

References

2017

Year

Çiğdem Usul Afşar, Mehmet Karabulut, Senem Karabulut, Murat Gönenç, Nergiz Dağoğlu, Murat Serilmez, Faruk Taş

Journal of Infection and Chemotherapy

Pancreatic CancerMedicineImmunologyPathologyImmune Checkpoint InhibitorPancreatic AdenocarcinomaImmunotherapyOncologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1